Rxivist logo

Vaccine genetics of IGHV1-2 VRC01-class broadly neutralizing antibody precursor naive human B cells

By Jeong Hyun Lee, Laura Toy, Justin T Kos, Yana Safonova, William R Schief, Corey T Watson, Colin Havenar-Daughton, Shane Crotty

Posted 02 Mar 2021
bioRxiv DOI: 10.1101/2021.03.01.433480

A successful HIV vaccine must overcome the hurdle of being able to activate naive precursor B cells encoding features within their germline B cell receptors (BCR) that allow recognition of broadly neutralizing epitopes. Knowledge of whether broadly neutralizing antibody (bnAb) precursor B cells are circulating at sufficient frequencies within individuals in communities heavily impacted by HIV may be important. Using a germline-targeting eOD-GT8 immunogen and high-throughput droplet-based single cell BCR sequencing, we demonstrate that large numbers of paired BCR sequences from multiple donors can be efficiently screened to elucidate precursor frequencies of rare, naive VRC01-class B cells. The results indicate that IGHV1-2 alleles incompatible with VRC01-class responses are relatively common in various human populations, and germline variation within IGHV1-2 associates with gene usage frequencies in the naive BCR repertoire.

Download data

  • Downloaded 341 times
  • Download rankings, all-time:
    • Site-wide: 110,483
    • In immunology: 3,352
  • Year to date:
    • Site-wide: 80,674
  • Since beginning of last month:
    • Site-wide: 113,974

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide